{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:21:46Z","timestamp":1791235306855,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the prevalence, clinical features, histological spectrum and outcomes of intra-renal involvement in patients with primary APS (PAPS), with particular attention to both aPL nephropathy (aPL-N) and non-aPL-N renal lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicentric retrospective case\u2013control study included 258 PAPS patients followed between 1984 and 2023 at two Italian referral centres. Patients with a biopsy-proven intra-renal involvement (n\u2009=\u200917) were compared with those without renal manifestations. Histologic classification followed the updated aPL-N criteria. Clinical, laboratory, therapeutic features, and 12-month renal responses were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen of 258 (7%) patients underwent renal biopsy. Two out of 17 (12%) presented with acute kidney injury, 5\/17 (29%) with nephrotic syndrome and 5\/17 (29%) had isolated urinary abnormalities; the remaining 5 patients presented with different combination of signs\/symptoms. Six (2.3%) were diagnosed with aPL-N, while 11 (4.2%) exhibited alternative glomerular lesions (e.g. membranous nephropathy, focal segmental glomerulosclerosis). Compared with controls, patients with intra-renal involvement had higher frequencies of CAPS (18% vs 0.4%, P\u2009=\u20090.001), thrombocytopenia (35% vs 10%, P\u2009=\u20090.006), epilepsy (24% vs 5%, P\u2009=\u20090.018) and LA positivity (100% vs 62%, P\u2009=\u20090.002). At 12\u2009months, partial renal response was observed in most cases, with a worse prognosis in those with aPL-N despite anti-thrombotic treatment. All non-aPL-N patients had aPL-related events, including thrombotic, obstetric and non-thrombotic manifestations, with non-aPL-N renal disease preceding these events in 45%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intra-renal involvement in PAPS is rare but heterogeneous, encompassing both vascular and glomerular pathologies. These findings support the need for heightened renal surveillance in PAPS, even in the absence of classic thrombotic manifestations, and highlight the importance of histologic assessment to guide tailored therapy. From a nephrologist\u2019s perspective, routine screening for aPL in glomerular disease assessment may be relevant, particularly by providing prognostic value for subsequent aPL-related events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf593","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:02:46Z","timestamp":1762952566000},"source":"Crossref","is-referenced-by-count":2,"title":["Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centres"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4976-9550","authenticated-orcid":false,"given":"Liala","family":"Moschetti","sequence":"first","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit and Department of Clinical and Experimental Sciences, ERN ReCONNET, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-9441","authenticated-orcid":false,"given":"Savino","family":"Sciascia","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID) and Department of Clinical and Biological Sciences, San Giovanni Bosco Hospital and University of Turin , Turin,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6511-4936","authenticated-orcid":false,"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit and Department of Clinical and Experimental Sciences, ERN ReCONNET, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Zappa","sequence":"additional","affiliation":[{"name":"Nephrology Unit and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-2606","authenticated-orcid":false,"given":"Massimo","family":"Radin","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID) and Department of Clinical and Biological Sciences, San Giovanni Bosco Hospital and University of Turin , Turin,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2757-7120","authenticated-orcid":false,"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit and Department of Clinical and Experimental Sciences, ERN ReCONNET, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Affatato","sequence":"additional","affiliation":[{"name":"Nephrology Unit and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Nalli","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit and Department of Clinical and Experimental Sciences, ERN ReCONNET, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-3218","authenticated-orcid":false,"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit and Department of Clinical and Experimental Sciences, ERN ReCONNET, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-4027","authenticated-orcid":false,"given":"Federica","family":"Mescia","sequence":"additional","affiliation":[{"name":"Nephrology Unit and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1686-5709","authenticated-orcid":false,"given":"Federico","family":"Alberici","sequence":"additional","affiliation":[{"name":"Nephrology Unit and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3678-6124","authenticated-orcid":false,"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit and Department of Clinical and Experimental Sciences, ERN ReCONNET, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID) and Department of Clinical and Biological Sciences, San Giovanni Bosco Hospital and University of Turin , Turin,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4355-9333","authenticated-orcid":false,"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit and Department of Clinical and Experimental Sciences, ERN ReCONNET, ASST Spedali Civili and University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2026022606021086300_keaf593-B1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.berh.2016.04.002","article-title":"Antiphospholipid syndrome","volume":"30","author":"Khamashta","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2026022606021086300_keaf593-B2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026022606021086300_keaf593-B3","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151 Suppl 1","author":"Cervera","year":"2017","journal-title":"Thromb Res."},{"key":"2026022606021086300_keaf593-B4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1159\/000529229","article-title":"Antiphospholipid syndrome and kidney involvement","volume":"48","author":"De Simone","year":"2023","journal-title":"Kidney Blood Press Res"},{"key":"2026022606021086300_keaf593-B5","doi-asserted-by":"crossref","first-page":"109735","DOI":"10.1016\/j.clim.2023.109735","article-title":"Antiphospholipid syndrome nephropathy: current knowledge and unanswered questions","volume":"255","author":"Xourgia","year":"2023","journal-title":"Clin Immunol"},{"key":"2026022606021086300_keaf593-B6","first-page":"1181","article-title":"Renal involvement in primary antiphospholipid syndrome","volume":"19","author":"Amigo","year":"1992","journal-title":"J Rheumatol"},{"key":"2026022606021086300_keaf593-B7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0961203310395052","article-title":"Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations","volume":"20","author":"Cervera","year":"2011","journal-title":"Lupus"},{"key":"2026022606021086300_keaf593-B8","first-page":"jrheum.2022","article-title":"Efforts to Better Characterize \u00abAntiphospholipid Antibody Nephropathy\u00bb for the 2023 ACR\/EULAR antiphospholipid syndrome classification criteria: renal pathology subcommittee report","author":"Barbhaiya","year":"2023","journal-title":"J Rheumatol"},{"key":"2026022606021086300_keaf593-B9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0272-6386(03)00352-4","article-title":"The expanding spectrum of renal diseases associated with antiphospholipid syndrome","volume":"41","author":"Fakhouri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2026022606021086300_keaf593-B10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2215\/CJN.00460110","article-title":"Renal Involvement in Primary Antiphospholipid Syndrome: retrospective Analysis of 160 Patients","volume":"5","author":"Sinico","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026022606021086300_keaf593-B11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0272-6386(12)80519-1","article-title":"Glomerulonephritis in a patient with anticardiolipin antibody","volume":"15","author":"Wilkowski","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"2026022606021086300_keaf593-B12","first-page":"3275","article-title":"Minimal change nephrosis and antiphospholipid syndrom: coincidental or associated?","author":"Vipul Chimanlal Chitalia","year":"1998"},{"key":"2026022606021086300_keaf593-B13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000027995","article-title":"Massive proteinuria as a main manifestation of primary antiphospholipid syndrome","volume":"66","author":"Levy","year":"1998","journal-title":"Pathobiology"},{"key":"2026022606021086300_keaf593-B14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000045804","article-title":"Idiopathic membranous glomerulonephritis associated with primary antiphospholipid syndrome","volume":"86","author":"Dorel","year":"2000","journal-title":"Nephron"},{"key":"2026022606021086300_keaf593-B15","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/ndt\/gfh910","article-title":"Steroid-responsive focal segmental glomerulosclerosis in primary antiphospholipid syndrome with successful pregnancy outcome","volume":"20","author":"Bhowmik","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2026022606021086300_keaf593-B16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5414\/CNP63471","article-title":"Kidney disease associated with primary antiphospholipid syndrome: clinical signs and histopathological features in an experience of five cases","volume":"63","author":"Saracino","year":"2005","journal-title":"Clin Nephrol"},{"key":"2026022606021086300_keaf593-B17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1191\/0961203306lu2343xx","article-title":"Letter To The Editor: antiphospholipid Syndrome and Minimal Change Nephropathy","volume":"15","author":"Rossi\u00f1ol","year":"2006","journal-title":"Lupus"},{"key":"2026022606021086300_keaf593-B18","first-page":"306","article-title":"Efficacy of rituximab in minimal change disease, an atypical renal manifestation of antiphospholipid syndrome","volume":"50","author":"D\u0142ugosz","year":"2022","journal-title":"Pol Merkur Lek Organ Pol Tow Lek"},{"key":"2026022606021086300_keaf593-B19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2026022606021086300_keaf593-B20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026022606021086300_keaf593-B21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","article-title":"GAPSS: the Global Anti-Phospholipid Syndrome Score","volume":"52","author":"Sciascia","year":"2013","journal-title":"Rheumatology"},{"key":"2026022606021086300_keaf593-B22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/qjmed\/93.7.457","article-title":"The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury","volume":"93","author":"Griffiths","year":"2000","journal-title":"QJM"},{"key":"2026022606021086300_keaf593-B23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"2026022606021086300_keaf593-B24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ekir.2023.01.018","article-title":"Clinical-pathological characteristics of renal injuries identify different clusters in patients with antiphospholipid antibodies","volume":"8","author":"Sciascia","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2026022606021086300_keaf593-B25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3899\/jrheum.2023-1096","article-title":"Antiphospholipid Antibodies (aPL) and thrombotic microangiopathy for the diagnosis of aPL nephropathy: you can\u2019t have one without the other","volume":"51","author":"Alpers","year":"2024","journal-title":"J Rheumatol"},{"key":"2026022606021086300_keaf593-B26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.V15777","article-title":"Anti-cardiolipin antibody and renal disease: a report three cases","volume":"1","author":"D\u2019Agati","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"2026022606021086300_keaf593-B27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/rheumatology\/kez596","article-title":"Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients","volume":"60","author":"Sciascia","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"2026022606021086300_keaf593-B28","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/art.41891","article-title":"Expert perspective: management of microvascular and catastrophic antiphospholipid syndrome","volume":"73","author":"Erkan","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2026022606021086300_keaf593-B29","doi-asserted-by":"crossref","first-page":"102889","DOI":"10.1016\/j.jaut.2022.102889","article-title":"Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy","volume":"132","author":"Rousselin","year":"2022","journal-title":"J Autoimmun"},{"key":"2026022606021086300_keaf593-B30","doi-asserted-by":"crossref","first-page":"sfae302","DOI":"10.1093\/ckj\/sfae302","article-title":"Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis","volume":"17","author":"Hoxha","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026022606021086300_keaf593-B31","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1177\/0961203319882506","article-title":"Clinical characteristics and risk factors of microvascular involvement in primary antiphospholipid syndrome: a longitudinal single-center study in China","volume":"28","author":"Sun","year":"2019","journal-title":"Lupus"},{"key":"2026022606021086300_keaf593-B32","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1093\/rheumatology\/keae397","article-title":"Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression","volume":"63","author":"Tektonidou","year":"2024","journal-title":"Rheumatology"},{"key":"2026022606021086300_keaf593-B33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clim.2018.03.001","article-title":"Treatment of antiphospholipid syndrome beyond anticoagulation","volume":"206","author":"Dobrowolski","year":"2019","journal-title":"Clin Immunol"},{"key":"2026022606021086300_keaf593-B34","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1177\/09612033221128742","article-title":"Immunosuppression use in primary antiphospholipid antibody-positive patients: descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (\u201cRegistry\u201d)","volume":"31","author":"Erton","year":"2022","journal-title":"Lupus"},{"key":"2026022606021086300_keaf593-B35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0272-6386(12)80378-7","article-title":"Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus","volume":"23","author":"Quereda","year":"1994","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"2026022606021086300_keaf593-B36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000501857","article-title":"Antiphospholipid antibodies in patients with membranous nephropathy","volume":"143","author":"Zhang","year":"2019","journal-title":"Nephron"},{"key":"2026022606021086300_keaf593-B37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/HAB-1996-7301","article-title":"Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice","volume":"7","author":"Levy","year":"1996","journal-title":"Hum Antibodies Hybridomas"},{"key":"2026022606021086300_keaf593-B38","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1177\/0961203317751645","article-title":"Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort","volume":"27","author":"Roccatello","year":"2018","journal-title":"Lupus"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf593\/65287234\/keaf593.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf593\/65287234\/keaf593.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf593\/65287234\/keaf593.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:02:24Z","timestamp":1772103744000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf593\/8322768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf593","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,13]]},"article-number":"keaf593"}}